Biotech News

Merit Medical to Participate at the J.P. Morgan Healthcare Conference

Merit Medical (MMSI)Merit MedicalConference / presentation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan Healthcare Conference, which is being held at The Westin St. Francis Hotel in San Francisco, California, January 12-15, 2026. To learn more, visit Healthcare Conference.

Martha G. Aronson, President and Chief Executive Officer, and Raul Parra, Chief Financial Officer, will present a company overview and update on Tuesday, January 13th at 4:30 pm Pacific Time / 7:30 pm Eastern Time.

Presentation materials for the conference will be posted to Merit’s investor relations website, Investor Events and Presentations - Merit Medical . A live audio webcast of the presentation will be accessible under the “Events” section of Merit’s investor relations website at Investor Events and Presentations - Merit Medical . A replay of the presentation will be available on this same website for approximately 90 days.

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.

CONTACTS

PR/Media Inquiries Sarah Comstock

Merit Medical Systems, Inc. +1-801-432-2864 | [email protected]

Investor Inquiries Mike Piccinino, CFA, IRC Westwicke - ICR +1-443-213-0509 | [email protected]

Related news

Merit Medical

Diversified Interventional MedTech Company Merit Medical is a global manufacturer and marketer of healthcare technology, with a broad product portfolio used across interventional and procedural medicine. Its business is driven by recurring device demand, product category breadth, international distribution, and execution in hospital and...

Recent company news

Stock data

Close
90.78 USD
Market cap
3.63B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States